Cell Therapeutics, Inc. Corporate Headquarters
501 Elliott Ave. W. #400
Seattle, WA 98119
T 206-282-7100
T 800-215-CELL (US)
F 206-284-6206
Systems Medicine LLC
T 520-750-1488
F 866-513-6059
Aequus BioPharma, Inc.
T 206-855-7802
F 206-201-7277
info@aequusbio.com
www.aequusbiopharma.com
Email inquiries by completing the Information Request form.
Investors and security analysts may also direct their inquiries to:
Ed Bell
Director, Investor Relations
T 206-272-4345
F 206-284-6206
invest@ctiseattle.com
Italian investors may contact:
Omar Al Bayaty, Barabino & Partners
T +39 02.72.02.35.35
o.albayaty@barabino.it
Transfer Agent
Shareholder inquiries on records/address changes, certificates, etc. should be directed to:
Computershare
T 312-588-4187
F 312-601-4332
www.computershare.com
Media should direct their inquiries to:
Dan Eramian
T 206-272-4343
C 206-854-1200
F 206-284-6206
DEramian@ctiseattle.com
Media in Italy:
Marina Riva, Barabino & Partners
T +39 02.72.02.35.35
F +39 02 8900519
m.riva@barabino.it
Medical information and clinical trial inquiries on our products can be made by completing our Medical Information Request.
If you are interested in employment with CTI, please check our Careers section.
If you have questions, comments or concerns about the functionality of this Web site, please direct your inquiries to our Webmaster.